Prilenia Therapeutics Israeli Company
Prilenia is a late clinical-stage biotechnology company founded in 2018 focused on the urgent mission to develop novel therapeutics to address the progression of neurodegenerative diseases and neurodevelopmental disorders. The initial focus of the company has been on Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS).
Health Tech & Life Sciences
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
Suggest an Alternative
Office Locations
Yakum, Israel
Naarden, Netherlands
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/prilenia-therapeutics
External links are provided for reference and verification purposes.